AIM-listed gold exploration company SolGold has made significant progress in defining additional soil gold-copper anomalies at its Cascabel mine in Ecuador, an update published by the company on Thursday indicated.
Exploration of the mine, which is a joint venture between SolGold and TSXV-listed Cornerstone Capital Resources, revealed defined additional gold, copper and molybdenum anomalies along with supporting elements.
The company update stated: "It is considered significant that extensive areas of gold, copper and molybdenum anomalis have been defined, and that these anomalous areas are open in most directions."
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company said that further soil sampling continued to deliver "very encouraging results". Trench sampling confirmed "outcropping gold-copper mineralisation" and rock alteration mapping also delivered "very encouraging results". Progress with components of the drill permitting process were also reported.
Malcolm Norris, Chief Executive Officer of SolGold commented: "These results are very encouraging. They give us high confidence that the T1 target area is a very worthy drill target exhibiting coincident soil geochemical anomalies in gold, copper and molybdenum, geophysical targets, outcropping porphyry mineralisation, and now supporting alteration mapping. To see the datasets aligning strengthens the target areas and with this our confidence grows."
MF
-
Should you sell in May this year?The market adage looks unlikely to apply in 2024, and global equities are proving resilient
-
Should you invest in UK equities?The FTSE 100 hit a record high this week, but UK equities remain unloved and undervalued compared to their global and US peers. Should you snap them up at a discount?
